Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term MICE. Found 15 abstracts

Kaiser WJ, Daley-Bauer LP, Thapa RJ, Mandal P, Berger SB, Huang CZ, Sundararajan A, Guo HY, Roback L, Speck SH, Bertin J, Gough PJ, Balachandran S, Mocarski ES. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proceedings of the National Academy of Sciences of the United States of America. 2014 May;111(21):7753-8.   PMCID: PMC4040608
Jenkins S, Raghuraman N, Eltoum I, Carpenter M, Russo J, Lamartiniere CA. Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats. Environmental Health Perspectives. 2009 Jun;117(6):910-5.   PMCID: PMC2702405
Yang DH, Smith ER, Cai KQ, Xu XX. c-fos Elimination Compensates for disabled-2 Requirement in Mouse Extraembryonic Endoderm. Development. Developmental Dynamics. 2009 Mar;238(3):514-23.   PMCID: PMC 2743073
Mao K, Kobayashi S, Jaffer ZM, Huang Y, Volden P, Chernoff J, Liang QR. Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes. Journal of molecular and cellular cardiology. 2008 Feb;44(2):429-34.
Rao A, Haywood J, Craddock AL, Belinsky MG, Kruh GD, Dawson PA. The organic solute transporter alpha-beta, Ost alpha-Ost beta, is essential for intestinal bile acid transport and homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 2008 Mar;105(10):3891-6.
Guo P, Wang XM, Liu LS, Belinsky MG, Kruh GD, Gallo JM. Determination of methotrexate and its major metabolite 7-hydroxymethotrexate in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2007 Apr;43(5):1789-95.
Singh MK, Cowell L, Seo S, O'Neill GM, Golemis EA. Molecular basis for HEFI/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell Biochemistry and Biophysics. 2007 Jan;48(1):54-72.
Yu Y, Fan JJ, Hui YQ, Rouzer CA, Marnett LJ, Klein-Szanto AJ, FitzGerald GA, Funk CD. Targeted cyclooxygenase gene (Ptgs) exchange reveals discriminant isoform functionality. Journal of Biological Chemistry. 2007 Jan;282(2):1498-506.
Zayed H, Xia L, Yerich A, Yant SR, Kay MA, Puttaraju M, McGarrity GJ, Wiest DL, McIvor RS, Tolar J, Blazar BR. Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and Sleeping Beauty transposon delivery. Molecular Therapy. 2007 Jul;15(7):1273-9.
Cai KQ, Klein-Szanto A, Karthik D, Edelson M, Daly MB, Ozols RF, Lynch HT, Godwin AK, Xu XX. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. Gynecologic Oncology. 2006 Nov;103(2):719-28.
Henderson GS, van Diest PJ, Burger H, Russo J, Raman V. Expression pattern of a homeotic gene, HOXA5, in normal breast and in breast tumors. Cellular Oncology. 2006 Jan;28(5-6):305-13.
Park ES, Oh HJ, Kruger WD, Jung SC, Lee JS. Recombinant adeno-associated virus mediated gene transfer in a mouse model for homocystinuria. Experimental and Molecular Medicine. 2006 Dec;38(6):652-61.
Pinte S, Guerardel C, Deltour-Balerdi S, Godwin AK, Leprince D. Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1. Oncogene. 2004 May;23(22):4023-31.
Guo P, Ma JG, Li SL, Gallo JM. Determination of paclitaxel in mouse plasma and brain tissue by liquid chromatography-mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2003 Dec;798(1):79-86.
Aoki M, Batista O, Bellacosa A, Tsichlis P, Vogt PK. The Akt kinase: Molecular determinants of oncogenicity. Proceedings of the National Academy of Sciences of the United States of America. 1998 Dec;95(25):14950-5.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term MICE

MICE EXPRESSION MOUSE SOLID-PHASE EXTRACTION DISRUPTION ADAPTER PROTEIN GENE PHOSPHORYLATION BREAST-CANCER KeyWords Plus: MRP3 INFLAMMATORY RESPONSE but whether these ovarian morphological changes in high-risk ovaries FOCAL ADHESION KINASE morphological changes are associated with BRCA 66 ovaries were from surgeries due to non-ovarian-related CpG island Cas-L CHICKEN-EMBRYO FIBROBLASTS c-Fos Disabled-2 (Dab2)-primitive endoderm-cell surface positioning-cell positioning TRANSPORTERS HOMEOBOX GENES relate to BRCA1 PHARMACOKINETICS NECROPTOSIS ABSORPTION HEMOPHILIA-B MYOSIN-VI MS RECEPTOR COACTIVATOR AIB1 CANCER CELLS dependovirus scaffolding adaptor MURINE MODEL homeotic gene REGION signal transduction PROTEIN-KINASE COLUMN MICRODIALYSIS MLKL RESISTANCE BRCA2 Results No statistically significant difference in frequency of these MEDIATED TYROSINE URINE PROGENITOR CELLS pharmacokinetic MS-brain tumor-cerebrospinal fluid-microdialysis-column switching HUMAN T-CELLS homocysteine with BRCA1 COWDEN-DISEASE BRCA2 genotypes or are FXR PERIPHERAL NERVOUS-SYSTEM MDS STEM-CELLS MILLER-DIEKER-SYNDROME HEF1 HUMAN B-CELLS DISEASE COX-2 CHOLESTASIS etiological factor we have investigated a recent cancer precursors is controversial Here CHOLESTEROL apoptosis women age 45-54 of either HR or NR groups the frequency of these histological BRCA2 mutations Rather population homocystinuria cancer NATURAL-HISTORY DOCETAXEL MAP KINASE P53 DOCKING PROTEIN FAMILY NEDD9 CELLS DEFICIENCY FAMILY-HISTORY stratification were assessed in a blinded fashion histolopathologic features was found between HR and NR groups However MUTATION PROPHYLACTIC OOPHORECTOMY SPECIMENS CARRIERS inclusion cysts and deep invaginations were found much more commonly in breast protein kinase B cystathionine beta-synthase NEGATIVE FEEDBACK-REGULATION BRCA1 MESSENGER-RNA PROSTACYCLIN GENE-THERAPY IMMUNODEFICIENCY GROWTH-FACTOR RECEPTOR POZ protein prophylactic oophorectomies P-GLYCOPROTEIN ARACHIDONIC-ACID GERMLINE invasion TAMOXIFEN RESISTANCE TRANSFORMATION 2 genotypes or reproductive history FACTOR-IX ESTROGEN CANCER-RISK epidermal growth factor receptor PROGRAMMED NECROSIS MYOCYTES TRANSGENIC CYSTATHIONINE-BETA-SYNTHASE CRK-ASSOCIATED SUBSTRATE CAS-L OVULATION 5 '-UTR CARDIAC GROWTH TUMOR-NECROSIS-FACTOR liver disease cholesterol-mouse model-nuclear receptor PTEN HOXB8 TUMORIGENESIS metastasis MUTATIONS PRECOLUMN DERIVATIZATION GONADOTROPINS AB Objective From analysis of pre-cancer ovarian tissues obtained from DOMAIN-LIKE ovaries from surgeries due to other non-ovarian-related cancer or GROWTH bisphenol A apoptosis-mammary cancer-proliferation-steroid receptor coactivators RATS phosphoinositide 3-kinase mouse VECTOR GLAND DEVELOPMENT PERINATAL EXPOSURE epithelial polarity organization-MAPK-mouse embryos CHROMOSOME 17P133 several studies reported the increased prophylactic oophorectomies DEVELOPING DROSOPHILA EYE STRAND BREAK REPAIR ENDOPEROXIDE-H SYNTHASE-1 MOLECULAR-BIOLOGY cancer (c) 2006 Elsevier Inc All rights reserved gene therapy collection of ovaries from prophylactic oophorectomies and control TNF
Last updated on Friday, June 05, 2020